← All indications
Cognitive Dysfunction
Diminished or impaired mental and/or intellectual function.
Subtype terms (2)
More specific conditions that are subtypes of Cognitive Dysfunction in the MeSH hierarchy.
- Chemotherapy-Related Cognitive Impairment
6 drugs (2 approved, 4 experimental)
- Postoperative Cognitive Complications
32 drugs (29 approved, 3 experimental)
Drugs by status
Approved for this indication (3)
Phase 4 trials (64)
- oxycodone
- Emoxypine
- Streptococcus thermophilus
- butylphthalide
- amphetamine
- remifentanil
- hydroxocobalamin
- metaxalone
- quetiapine
- nimodipine
- vortioxetine
- rivastigmine
- lactobacillus plantarum
- clonidine
- guanfacine
- remimazolam
- ioflupane i-123
- fish oil
- choline
- sitagliptin
- lisdexamfetamine
- nortriptyline
- atropine
- duloxetine
- donepezil
- simvastatin
- chickpea
- qinggongshoutao
- bifidobacterium longum
- acetaminophen
- +34 more
Phase 3 trials (40)
- lisinopril
- mk 6240
- inosine
- shenwu
- somatropin
- amlodipine
- tocotrienol
- chicken extract
- 3,4-Methylenedioxymethamphetamine
- mazdutide
- ketamine
- levetiracetam
- indapamide
- escitalopram
- sodium succinate
- vitamin d3
- candesartan
- silymarin
- sodium butyrate
- testosterone
- prednisone
- cariprazine
- curcumin
- modafinil
- donanemab
- memantine
- aducanumab
- monosialotetrahexosyl ganglioside
- ergothioneine
- dapagliflozin
- +10 more
Phase 2 trials (125)
- eltoprazine
- baricitinib
- ginkgo
- fesoterodine
- psilocybin
- metoprolol
- spermidine
- pioglitazone
- ue2343
- bradanicline
- jnj-63733657
- ibuprofen
- gingko biloba
- sage-718
- isosorbide
- tesamorelin
- nicorandil
- xanamem
- sirolimus
- uridine monophosphate
- pittsburgh compound b
- mecobalamin
- estradiol
- conjugated equine estrogens
- autologous adipose-derived mesenchymal stem cells
- semaglutide
- acetylsalicylic acid
- lamivudine
- vx-745
- gulingji
- +95 more
Phase 1 trials (52)
- solanezumab
- jnj-40346527
- kyn-5356
- cyclophosphamide
- tetrahydrocannabinol
- raltegravir
- doxorubicin
- alpha-lipoic acid
- centella asiatica
- hpp854
- aftobetin
- phenserine
- irdabisant
- glycine
- 18f-pf-06445974
- avocado
- brexanolone
- mefloquine
- ct1812
- blood plasma
- nio752
- cpg 1018
- abt-957
- vix001
- emtricitabine
- vu319
- dabigatran
- phenytoin
- pramlintide
- ps13
- +22 more
Other trials (79)
- beta carotene
- prazosin
- rituximab
- cherry
- cow milk
- acarbose
- esketamine
- alpha-lactalbumin
- lactobacillus helveticus
- porcine brain-derived peptide preparation
- sertraline
- Laronidase
- aprepitant
- apolipoprotein
- bacopa monnieri
- beta-glucans
- medium chain triglyceride
- armillariella mellea
- astaxanthin
- naproxen
- l-epigallocatechin
- vitamin e
- cocoa bean
- citalopram
- linagliptin
- multivitamins
- methylprednisolone
- ginger
- lactobacillus rhamnosus
- lavender
- +49 more
Organizations
Organization Involved with Phase 4 Indications (136)
- Avid Radiopharmaceuticals
- Eisai
- Takeda
- Shire
- Forest Laboratories
- Gilead Sciences
- Schering-Plough
- Eli Lilly
- Pfizer
- Novartis
- Baxalta
- Clinvest
- GlaxoSmithKline
- Milsing d.o.o.
- Sponsor GmbH
- Teva
- Boehringer Ingelheim
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Fundacio Lluita Contra la SIDA
- Research Foundation for Mental Hygiene, Inc.
- National Institutes of Health (NIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Mental Health (NIMH)
- National Institute on Aging (NIA)
- National Neuroscience Institute
- Huazhong University of Science and Technology
- Aarhus University
- University of Pennsylvania
- Maastricht University
- University of Pittsburgh
- +106 more
Organization Involved with Phase 3 Indications (81)
- Merck
- Ipsen
- FORUM Pharmaceuticals Inc
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- INC Research
- Materia Medica Holding
- North China Pharmaceutical Group Corporation
- Shanghai Greenvalley Pharmaceutical Co., Ltd.
- Polysan, Ltd.
- Solvay
- Ontario Neurotrauma Foundation
- ZonMw: The Netherlands Organisation for Health Research and Development
- National Cancer Institute (NCI)
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Neurological Disorders and Stroke (NINDS)
- London Health Sciences Centre
- Boston University
- Brock University
- Clinical Research Centre, Malaysia
- Cornell University
- Garvan Institute of Medical Research
- University of Washington
- Instituto Mexicano del Seguro Social
- Johns Hopkins University
- Michigan State University
- NRG Oncology
- Oregon Health and Science University
- University of The West Indies
- Texas Health Resources
- Universidad de Colima
- +51 more
Organization Involved with Phase 2 Indications (139)
- AC Immune SA
- AbbVie
- Toyama
- Targacept
- Cephalon
- Servier
- Roche
- Astellas
- AstraZeneca
- Merck Serono
- Sanofi
- Biogen
- Aptinyx
- Mylan
- Purdue Pharmaceuticals
- AZTherapies, Inc.
- Allon Therapeutics
- Araclon Biotech S.L.
- Avraham Pharmaceuticals Ltd
- Cerespir
- Chiesi
- Cognition Therapeutics
- EIP Pharma, LLC
- Memory Pharmaceuticals
- Merz
- Neurim Pharmaceuticals Ltd.
- Parexel
- Sage Therapeutics
- RespireRx
- Schwabe
- +109 more
Organization Involved with Phase 1 Indications (32)
- Bayer
- Cognoptix, Inc.
- DSM
- High Point Pharmaceuticals, LLC.
- Piramal
- Annovis Bio
- Theranexus
- Tetra Discovery Partners
- Institute for Neurodegenerative Disorders
- Mclean Hospital
- Neurological Associates of West Los Angeles
- The Rogosin Institute
- Tufts University
- University of Rhode Island
- Wageningen University
- West Virginia University
- University of Zagreb
- Nucleus Network Ltd
- François Rabelais University
- University of Lille
- California Clinical Trials
- University of Oxford
- CEDRA Clinical Research
- University of Alabama, Birmingham
- ICON
- American Psychiatric Foundation
- NZO: Dutch Dairy Association
- Alzheimer’s Drug Discovery Foundation
- Klinički Bolnički Centar Zagreb
- Hospital Angeles Tijuana
- +2 more
Organization Involved with Other Experimental Indications (83)
- Aboca
- Biomarin
- Naurex
- Immunotec Inc.
- Menarini Group
- Neurological Research Center
- Fundacion IMIM
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Slovak Academy of Sciences
- UCLA Medical Center
- Anhui Medical University
- Cedars-Sinai Medical Center
- Hoosier Cancer Research Network
- Hypoglycaemia Research Group
- Loma Linda University
- Makassed General Hospital
- Los Angeles Biomedical Research Institute
- Medical College of Wisconsin
- Nanjing Medical University
- Nanjing University
- National Cheng Kung University
- Northern State Medical University
- Northumbria University
- Shanghai University of Traditional Chinese Medicine
- Shengjing Hospital
- Texas A&M University
- University Hospital Hradec Kralove
- University of Dundee
- University of East Anglia
- University of Lausanne
- +53 more